CORRECTING and REPLACING LOGO: NAACOS and Innovaccer Latest Report Shows 64% of Healthcare Leaders Expect Revenue Gains from Value-Based Care in 2025
SAN FRANCISCO--(BUSINESS WIRE)--Please replace the logo with the accompanying corrected logo.
The release reads:
NAACOS AND INNOVACCER LATEST REPORT SHOWS 64% OF HEALTHCARE LEADERS EXPECT REVENUE GAINS FROM VALUE-BASED CARE IN 2025
New research explores the evolving landscape, key investment priorities, and adoption barriers shaping value-based care in the U.S.
Innovaccer Inc., a leading healthcare AI company, in collaboration with the National Association of ACOs (NAACOS), today announced the release of their joint report, ' The State and Science of Value-Based Care 2025.' Based on a nationwide survey of 168 healthcare leaders across 142 organizations, the study uncovers the progress, pain points, and investment signals driving value-based care (VBC) strategies forward.
As the healthcare industry moves toward outcomes-based models, 64% of surveyed organizations expect a positive revenue shift from value-based care in 2025, marking a sharp increase in confidence despite ongoing structural and operational challenges.
'As the shift to value-based care accelerates, the research highlights a critical truth: successful transformation demands more than just intent, it requires deep investments in data, technology, and partnerships,' said Abhinav Shashank, cofounder and CEO of Innovaccer. 'This joint report with NAACOS provides clarity and direction for healthcare leaders navigating the complexities of modern reimbursement models.'
Key findings in the report include:
64% of healthcare organizations expect higher VBC-driven revenue in 2025 compared to 2024.
87% of respondents cite financial risk as the top barrier to adoption, followed by provider readiness (80%), lack of interoperability (75%), and high technology cost (67%).
74% say greater financial support and incentives would significantly accelerate adoption.
70% express optimism about AI's role in enabling predictive analytics and scaling VBC strategies.
'At the foundation of accountable care and population health management lies the strategic use of integrated data that drives insights and action,' said Emily D. Brower, President and CEO of NAACOS. 'This comprehensive approach enables a deeper understanding of community, population, and individual patient needs. This report highlights how technology, collaboration, and infrastructure can support providers in accountable care to drive innovation in care delivery.'
The report also highlights how high-performing organizations are laying the foundation for long-term VBC success through unified data platforms, advanced analytics, and integrated care delivery solutions.
Download the full report here.
About Innovaccer
Innovaccer activates the flow of healthcare data, empowering providers, payers, and government organizations to deliver intelligent and connected experiences that advance health outcomes. The Healthcare Intelligence Cloud equips every stakeholder in the patient journey to turn fragmented data into proactive, coordinated actions that elevate the quality of care and drive operational performance. Leading healthcare organizations like CommonSpirit Health, Atlantic Health, and Banner Health trust Innovaccer to integrate a system of intelligence into their existing infrastructure— extending the human touch in healthcare. For more information, visit innovaccer.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
13 minutes ago
- Business Upturn
Mary Kay Inc. Awards 10 Grants to Young Innovators at 2025 Regeneron International Science and Engineering Fair
By Business Wire Published on May 29, 2025, 09:34 IST Dallas, United States: Mary Kay Inc., a global advocate for furthering young women's education and encouraging youth to follow their STEM dreams, returned for a second year as a Special Awards Organization at the Regeneron International Science and Engineering Fair (Regeneron ISEF) in Columbus, Ohio. Ten grants totaling nearly $10,000 were awarded to standout high school-aged students excelling in innovative projects spanning topics from finding cures for cancers affecting women to sustainable packaging innovation and protecting our planet's most valuable resources. This press release features multimedia. View the full release here: Kristin Dasaro, Director, Package Engineering and Sustainability at Mary Kay, greets Brazilian cancer researcher, Carolina de Araujo Pereira da Silva, who received back-to-back awards from Mary Kay for innovative findings in the malignancy of tumors. (Photo Credit: Mary Kay Inc.) Each year, the event convenes nearly 2,000 participants representing more than 60 countries, with a total award pool offering over $9 million in awards and scholarships and invitations to corporate and academic events with elite global leaders in STEM. Celebrating its 75th year, ISEF, a program of Society for Science, is the world's largest pre-college global STEM competition. Through a global network of local, regional, and national science fairs, millions of students are encouraged to explore their passion for scientific inquiry. Each spring, a group of these students is selected as finalists and offered the opportunity to compete for approximately $9 million in awards and scholarships at the annual Regeneron ISEF. 'The ingenuity, passion, and innovation demonstrated by these young STEM leaders are awe-inspiring,' said Carrissa Dowdy, Manager of Product Formulation at Mary Kay. 'Their work has the potential to transform industries, drive sustainable advancements, and accelerate major breakthroughs in fields like cancer research, material science, and environmental engineering. Mary Kay is proud to stand behind them as they shape the future of STEM.' MEET THE STUDENT STEM LEADERS 1. Pragathi Kasani-Akula (GA, USA) Multi-Color Magneto-Fluorescent Nanoarchitectures for the Targeted Identification of Exosomes of Triple Negative Breast Cancer 2. Grace Liu (NY, USA) Evaluating Gender Disparities Due to Decision-Making Under Uncertainty in Entrepreneurship: A Panel Data Analysis 3. Alina Albeik (VA, USA) Implications of Resveratrol on Memory Retention in Dugesia tigrina 4. Kaili Tseng and Leila Gheysar (CA, USA) Bombyx mori Antimicrobial Peptides: A Novel and Sustainable Catalyst for Cancer Cell Growth Inhibition and Death 5. Elisabeth Fischermann and Tom Kressbach (Bavaria, Germany) On the Hunt for Free Radicals With a Blue Light Reaction 6. Ela Doruk Korkmaz (Istanbul, Turkey) Investigation of Potential Anti-Cancer Impacts of Coffee Bean-Derived Exosomes Through Anti-Proliferative and Apoptosis Inducing Effects on Melanoma Skin Cancer Cells via Mitogen-Activated Protein Kinase Signaling Pathway 7. Carolina de Araujo Pereira da Silva* (Rio de Janeiro, Brazil) Salinomycin as a Molecular Trojan Horse for Targeting Mn-Induced Malignancy in Aggressive Tumors 8. Sofia Nunes (Maranhao, Brazil) Formulation of Low-Cost Artificial Skin for Cellular Regeneration and Severe Burns Treatment 9. Margareth Ac-ac (Negros Oriental, Philippines) SKIMP: Artificial Intelligence- Convolutional Neural Network (CNN) Portable Skin Cancer Detection Device With Skin Cancer Notifier Python-Based Program 10. Kamila Rotger-Costas and Miranda Sanz-Alvarez (Guaynabo and Caguas, Puerto Rico) EcoReishiFlex: An Innovative Sustainable Biodegradable Plastic Alternative Made From Ganoderma lucidum (Reishi Fungi) Polysaccharides *Carolina de Araujo Pereira da Silva is a two-time Mary Kay Young Women in STEM grant recipient for her outstanding contributions to the cancer research field. Her 2024 prize money was utilized toward furthering her presented project – Rock the Metals! Investigating Manganese as a Trigger of Malignancy and Metal Transporters as Targets in Cancer Treatment which elevated her 2025 award-winning submission. About Mary Kay One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women's lives. That dream has blossomed into a global company with millions of independent sales force members in more than 40 markets. For over 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at Find us on Facebook, Instagram, and LinkedIn, or follow us on X. View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same. Business Wire is an American company that disseminates full-text press releases from thousands of companies and organizations worldwide to news media, financial markets, disclosure systems, investors, information web sites, databases, bloggers, social networks and other audiences.
Business Wire
25 minutes ago
- Business Wire
Diagnostics.ai Launches Industry's First CE-IVDR Certified Transparent AI Platform for Molecular Diagnostics as Regulatory Deadlines take Effect
LONDON--(BUSINESS WIRE)-- Revolutionary Platform Sets New Benchmark for Transparency and Compliance in Diagnostic AI First-of-its-kind platform for molecular diagnostics shows exactly how AI-generated PCR result analyses are achieved - delivering transparency, trust, and CE-IVDR compliance. As the May 26th CE-IVDR compliance deadline comes into effect, launches the industry's first fully-transparent machine learning platform for clinical real-time PCR diagnostics – demonstrating exactly how each result was achieved, a first for molecular-testing machine learning. The technology is backed by over 15 years of experience and millions of successfully processed samples with >99.9% proven accuracy. The CE-IVDR Strategic Advantage Platform is response to the new wave of stringent EU regulations under the In Vitro Diagnostic Medical Devices Regulation (IVDR), which demand heightened standards for diagnostic accuracy, reproducibility, and algorithm transparency. 'While most diagnostic algorithms remain an impenetrable 'black box,' the API was engineered with transparency included from the ground up,' said Aron Cohen, Chief Executive Officer of 'Our platform delivers transparency and traceability that meet and support the highest standards set by CE-IVDR, making the AI decision-making process visible, understandable, and traceable.' Key Innovations of the Transparent AI Architecture platform is built around a pioneering 'model-aware' architecture, enabling laboratories to understand the suggestions that the AI makes. Highlighted Benefits: Transparent Result Attribution Directly shows how and why a result was achieved, eliminating reliance on post-hoc interpretations. Real-Time Model Monitoring Allows laboratories to track model performance and detect drift in real time – meeting IVDR Article 72 requirements. Per-Test Algorithm Accountability Easy to understand per test reports, ensuring comprehensive auditability. Clinician-Ready Explanation Generation Provides laboratory professionals and clinicians with clear, auditable explanations of diagnostic outcomes, supporting informed clinical communication. 'Our platform bridges the gap between compliance necessity and clinical confidence,' said Dr. Brian Glenville MD, Chairman of 'Laboratory directors can now explain to regulators, clinicians, and patients exactly how each diagnostic result was determined, creating a new level of trust in molecular diagnostics.' Now Available Across Europe The CE-IVDR Strategic Advantage Platform - including the CE-IVDR and MHRA registered AI API, as well as technical, regulatory and implementation support - is now available across Europe for both clinical laboratories and diagnostic manufacturers, empowering them to meet and exceed regulatory obligations while achieving deeper confidence in diagnostic results. Already in successful use in the U.S., U.K., and other countries, is trusted by leading laboratories for its reliable and transparent diagnostic performance. About is an established leader in AI-powered PCR analysis with over 15 years of experience serving clinical laboratories worldwide. The company has processed millions of samples with documented >99.9% accuracy and maintains full CE-IVDR and MHRA compliance. transparent machine learning platform transforms laboratory efficiency while enabling regulatory compliance.
Business Wire
25 minutes ago
- Business Wire
Boyd to Exhibit at The Battery Show Europe 2025 in Stuttgart, Germany
STUTTGART, Germany--(BUSINESS WIRE)-- Boyd, a leader in battery thermal propagation prevention and thermal runaway containment technology, will exhibit at The Battery Show Europe, taking place June 3 – 5, 2025 in Stuttgart, Germany. This is a valuable opportunity to collaborate with industry innovators to address evolving challenges European eMobility battery designers face. We are helping eMobility leaders design thermal runaway prevention to enhance battery safety and reliability. Boyd experts will be on site to discuss how its battery technologies proactively and safely prevent and contain battery thermal runaway events. Boyd employs multi-functional, complex solutions designed for cell-to-cell application that absorb impact, vibration and movement, dissipate cell heat, and act as a barrier to quickly isolate extreme heat or flame in the unlikely event battery safety design features fail to prevent cell-to-cell thermal runaway propagation. Boyd technologies maintain homogenous temperatures across battery cells, enable faster charge / discharge cycles, reduce battery overheating, and isolate and prevent catastrophic battery damage. Experts will also be available to discuss how customers can leverage Boyd's new state-of-the-art Battery Material Safety Lab announced last month. Boyd is helping customers safely accelerate battery design and time-to-market as a one-stop-shop to design, validate, and manufacture integrated thermal runaway prevention technologies. 'Boyd has exhibited at The Battery Show Europe for many years, and we are honored to continue our participation in 2025,' said Kevin Kettler, Boyd Chief Transformation Officer. 'This event is a valuable opportunity for global OEMs, tier suppliers, and industry innovators to regionally collaborate and address the evolving challenges European eMobility battery designers face today. We are helping regional eMobility leaders design thermal runaway prevention and containment solutions that enhance battery safety and reliability.' Visit Boyd at booth 10-B16 to learn more about its innovative thermal runaway prevention and containment solutions. About Boyd Boyd is the trusted global innovator of sustainable solutions that make our customers' products better, safer, faster, and more reliable. Our innovative engineered materials and thermal solutions advance our customers' technology to maximize performance in the world's most advanced data centers; enhance reliability and extend range for electric and autonomous vehicles; advance the accuracy of cutting-edge personal healthcare and diagnostic systems; enable performance-critical aircraft and security technologies; and accelerate innovation in next-generation electronics and human-machine-interface. Core to Boyd's global manufacturing is a deep commitment to protecting the environment with sustainable, scalable, lean, strategically located regional operations that reduce waste and minimize carbon footprint. We empower our employees, develop their potential, and inspire them to do the right things with integrity and accountability to champion our customers' success.
